Upwork Inc (NASDAQ: UPWK) is well-positioned to benefit from the pandemic-driven shift to remote teams with and freelancing becoming “an increasingly larger portion of the overall workforce,” according to BofA Securities.
Supply chain issues may adversely impact the sales recovery at Kohl's Corporation (NYSE: KSS) and offset the progress on women’s category as well as the benefit associated with the new Sephora locations, according to BofA Securities.
Boeing Co (NYSE: BA) is poised to benefit from an inflection in global travel and an improved outlook for commercial aircraft deliveries, according to Bernstein.
Although DRAM price reductions caused investor concerns, Micron Technology, Inc’s (NASDAQ: MU) guidance for the first quarter of fiscal 2022 reflects stable margins, according to BofA Securities.
With an expanding product portfolio, Okta Inc (NASDAQ: OKTA) is poised to gain a share in the growing market for identity and access management (IAM), estimated at $40 billion, according to Morgan Stanley.
Part A results from the trial of Seelos Therapeutics Inc’s (NASDAQ: SEEL) intranasal ketamine product candidate, SLS-002, and the clarity around the timing of the Part B data release call for a change in recommendation, according to Roth Capital.
Although Carnival Corp (NYSE: CCL) made progress on resuming cruise operations in the third quarter, the recovery already seems largely priced in, according to BofA Securities.
While Humana Inc.’s (NYSE: HUM) stock already seems to price in the near-term concerns around rebounding medical costs and high COVID-19 costs, it offers an opportunity to gain exposure to “the post-COVID accelerating growth environment and associated 2022 inflection,” according to SVB Leerin